Mammoth Biosciences
Director/Senior Director, Regulatory Affairs, Therapeutics
Mammoth Biosciences, Brisbane, California, United States,
Mammoth BioSciences
OPPORTUNITY
Mammoth is hiring aDirector/Sr. Director, Regulatory Affairs, Therapeutics, to lead the regulatory activities of our growing CRISPR-based therapeutic programs as we bring them from concept to market.
This role will be responsible for coordinating all aspects of regulatory strategy, interactions, and filings. The Director/Sr. Director will oversee and partner with several external consultants in the short term.
In the longer term, they will be responsible for building out the regulatory function for the company.
This is a leadership position that will play a critical role in the successful development of the Mammoth therapeutic candidates.
The role will report into the SVP of Translational Science.
KEY RESPONSIBILITIES
Lead, define and manage the strategic regulatory direction for Mammoth's pipelineEstablish the regulatory pathway to IND filing in complex programs using a novel gene editing technologyCollaborate with various regulatory consultants, clinical advisory board members, and board members to maintain regulatory knowledge of US and EUInterface with CMC, nonclinical research and clinical research personnel and help keep them apprised of new regulations, standards, policies, and guidance issued by regulatory authoritiesServe as a liaison between the company and regulatory agenciesMaintain real time understanding of Mammoth's target patient populationDevelop and coordinate high quality submissions for global clinical trialsREQUIRED QUALIFICATIONS
Bachelor's degree in life sciencesMinimum of 10+ years of experience in the biotechnology and/or biopharmaceutical industry (Master's degree with 8+ years of experience or PhD with 6+ years of experience); Sr. Director: Minimum of 12+ years of experience in the biotechnology and/or biopharmaceutical industry (Master's degree with 10+ years of experience or PhD with 8+ years of experience).Minimum of 7 years in a Regulatory capacity with experience in drug developmentExperience with US and clinical trial submissions through with CBER/OTAT or ex-US equivalentProven track record with regulatory agenciesStrong project management skills and drive for excellenceExperience with gene therapy products regulatory requirementsProven success interacting efficiently with Preclinical Research, CMC, and ClinicalAbility to be onsite a minimum of 2-3x/ per week from a reasonable commuting distance within the Bay AreaPREFERRED QUALIFICATIONS
Advanced degree in life sciencesCreative problem solverBENEFITS
Company-paid health/vision/dental benefitsUnlimited vacation and generous sick timeCompany-sponsored meals and snacksWellness, caregiver and ergonomics benefits401(k) with company matchingBase Salary Range: $ 205,000 - $260,000Actual base salary will be determined by relevant professional experience, applicable skills, and internal equity.COMPANY
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company's ultracompact proteins are designed to enable
in vivo
gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential
in vivo
gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth's deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.
It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law. This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.Mammoth Biosciences requires that all employees be vaccinated against COVID-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law.
PIda7f35c13e35-37448-34240164
OPPORTUNITY
Mammoth is hiring aDirector/Sr. Director, Regulatory Affairs, Therapeutics, to lead the regulatory activities of our growing CRISPR-based therapeutic programs as we bring them from concept to market.
This role will be responsible for coordinating all aspects of regulatory strategy, interactions, and filings. The Director/Sr. Director will oversee and partner with several external consultants in the short term.
In the longer term, they will be responsible for building out the regulatory function for the company.
This is a leadership position that will play a critical role in the successful development of the Mammoth therapeutic candidates.
The role will report into the SVP of Translational Science.
KEY RESPONSIBILITIES
Lead, define and manage the strategic regulatory direction for Mammoth's pipelineEstablish the regulatory pathway to IND filing in complex programs using a novel gene editing technologyCollaborate with various regulatory consultants, clinical advisory board members, and board members to maintain regulatory knowledge of US and EUInterface with CMC, nonclinical research and clinical research personnel and help keep them apprised of new regulations, standards, policies, and guidance issued by regulatory authoritiesServe as a liaison between the company and regulatory agenciesMaintain real time understanding of Mammoth's target patient populationDevelop and coordinate high quality submissions for global clinical trialsREQUIRED QUALIFICATIONS
Bachelor's degree in life sciencesMinimum of 10+ years of experience in the biotechnology and/or biopharmaceutical industry (Master's degree with 8+ years of experience or PhD with 6+ years of experience); Sr. Director: Minimum of 12+ years of experience in the biotechnology and/or biopharmaceutical industry (Master's degree with 10+ years of experience or PhD with 8+ years of experience).Minimum of 7 years in a Regulatory capacity with experience in drug developmentExperience with US and clinical trial submissions through with CBER/OTAT or ex-US equivalentProven track record with regulatory agenciesStrong project management skills and drive for excellenceExperience with gene therapy products regulatory requirementsProven success interacting efficiently with Preclinical Research, CMC, and ClinicalAbility to be onsite a minimum of 2-3x/ per week from a reasonable commuting distance within the Bay AreaPREFERRED QUALIFICATIONS
Advanced degree in life sciencesCreative problem solverBENEFITS
Company-paid health/vision/dental benefitsUnlimited vacation and generous sick timeCompany-sponsored meals and snacksWellness, caregiver and ergonomics benefits401(k) with company matchingBase Salary Range: $ 205,000 - $260,000Actual base salary will be determined by relevant professional experience, applicable skills, and internal equity.COMPANY
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company's ultracompact proteins are designed to enable
in vivo
gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential
in vivo
gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth's deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.
It is our policy and intent to provide equal opportunity to all persons without regard to race, color, religion, political affiliation, sex/gender (including gender expression/identity, pregnancy, childbirth and related medical conditions), marital status, registered domestic partner status, sexual orientation, age, ancestry, national origin, veteran status, disability, medical condition, genetic characteristics, and/or any other basis protected by law. This policy covers all facets of employment including, but not limited to: recruitment, selection, placement, promotions, transfers, demotions, terminations, training, and compensation.Mammoth Biosciences requires that all employees be vaccinated against COVID-19 as a condition of at-will employment, with exceptions for medical or religious reasons in compliance with local, state, and federal law.
PIda7f35c13e35-37448-34240164